William Rastetter, Director at Illumina, holds 37.49K shares in Neurocrine (Ticker: NBIX), holds 617.42K shares in Fate Therapeutics (Ticker: FATE), holds 390.58K shares in Regulus (Ticker: RGLS). Most recently, William Rastetter Sold ― shares of Neurocrine on Aug 16, 2024 for an estimated value of 2.09M.
William Rastetter latest transaction was an Informative Sell of $2.09M.
What was William Rastetter's most profitable transaction?
William Rastetter’s most profitable transaction was an Informative Buy of FATE stock on November 28, 2016. The return on the trade was 39.10%.
What is William Rastetter's role in Illumina?
William Rastetter's role in Illumina is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.